Gain exposure to Israel’ s vibrant economy, which has historically demonstrated consistent growth and is driven by the innovative spirit that earned it the nickname, the Start-Up Nation.

Call us at 800.826.2333 vaneck. com / isra

An investment in the Fund may be subject to risks which include, among others, investing in Israeli issuers, foreign securities, foreign currency, depositary receipts, financials sector, health care sector, information technology sector, small-, medium- and micro-capitalization companies, equity securities, market, operational, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium / discount risk and liquidity of fund shares, non-diversified and concentration risks, all of which may adversely affect the Fund. Foreign investments are subject to risks, which include changes in economic and political conditions, foreign currency fluctuations, changes in foreign regulations, and changes in currency exchange rates which may negatively impact the Fund’ s return. Small-, medium- and micro-capitalization companies may be subject to elevated risks.

Fund shares are not individually redeemable and will be issued and redeemed at their Net Asset Value( NAV) only through certain authorized broker-dealers in large, specified blocks of shares called“ creation units” and otherwise can be bought and sold only through exchange trading. Shares may trade at a premium or discount to their NAV in the secondary market. You will incur brokerage expenses when trading fund shares in the secondary market. Past performance is no guarantee of future results. Returns for actual fund investments may differ from what is shown because of differences in timing, the amount invested, and fees and expenses.

Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. To obtain a prospectus and summary prospectus, which contain this and other information, call 800.826.2333 or visit vaneck. com. Please read the prospectus and summary prospectus carefully before investing.

Van Eck Securities Corporation, Distributor, 666 Third Avenue, New York, NY 10017